Steve Harris, MD
CLINICAL PROFESSOR-VOLUNTEER
Medicine
School of Medicine

Publications (38)

Top publication keywords:
Insurance, HealthRaloxifene HydrochlorideOsteoporosis, PostmenopausalFractures, BoneMedicare Part CEtidronic AcidBone DensityBone Density Conservation AgentsEndocrinologyOsteoporotic FracturesDiphosphonatesClinical Trials, Phase III as TopicOsteoporosisTeriparatideDrug Administration Schedule

• The role of osteoanabolic agents in the management of patients with osteoporosis.
  Postgraduate medicine 2022 McClung MR, Rothman MS, Lewiecki EM, Hanley DA, Harris ST, Miller PD, Kendler DL
• AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS- 2020 UPDATE EXECUTIVE SUMMARY.
  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2020 Camacho PM, Petak SM, Binkley N, Diab DL, Eldeiry LS, Farooki A, Harris ST, Hurley DL, Kelly J, Lewiecki EM, Pessah-Pollack R, McClung M, Wimalawansa SJ, Watts NB
• AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS-2020 UPDATE.
  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2020 Camacho PM, Petak SM, Binkley N, Diab DL, Eldeiry LS, Farooki A, Harris ST, Hurley DL, Kelly J, Lewiecki EM, Pessah-Pollack R, McClung M, Wimalawansa SJ, Watts NB
• History of etidronate.
  Bone 2020 Watts NB, Chesnut CH, Genant HK, Harris ST, Jackson RD, Licata AA, Miller PD, Mysiw WJ, Richmond B, Valent D
• Western Osteoporosis Alliance Clinical Practice Series: Treat-to-Target for Osteoporosis.
  The American journal of medicine 2019 Lewiecki EM, Kendler DL, Davison KS, Hanley DA, Harris ST, McClung MR, Miller PD

Show all (33 more) Hide

• Proceedings of the 2017 Santa Fe Bone Symposium: Insights and Emerging Concepts in the Management of Osteoporosis.
  Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2017 Lewiecki EM, Bilezikian JP, Carey JJ, Dell RM, Gordon CM, Harris ST, McClung MR, Miller PD, Rosenblatt M
• Diagnosis and Treatment of Osteoporosis Before and After Fracture: A Side-by-Side Analysis of Commercially Insured and Medicare Advantage Osteoporosis Patients.
  Journal of managed care & specialty pharmacy 2017 Weaver J, Sajjan S, Lewiecki EM, Harris ST
• Prevalence and Cost of Subsequent Fractures Among U.S. Patients with an Incident Fracture.
  Journal of managed care & specialty pharmacy 2017 Weaver J, Sajjan S, Lewiecki EM, Harris ST, Marvos P
• Western Osteoporosis Alliance Clinical Practice Series: Evaluating the Balance of Benefits and Risks of Long-Term Osteoporosis Therapies.
  The American journal of medicine 2017 Hanley DA, McClung MR, Davison KS, Dian L, Harris ST, Miller PD, Lewiecki EM, Kendler DL, Writing Group for the Western Osteoporosis Alliance
• AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS - 2016.
  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2016 Camacho PM, Petak SM, Binkley N, Clarke BL, Harris ST, Hurley DL, Kleerekoper M, Lewiecki EM, Miller PD, Narula HS, Pessah-Pollack R, Tangpricha V, Wimalawansa SJ, Watts NB
• AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS - 2016--EXECUTIVE SUMMARY.
  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2016 Camacho PM, Petak SM, Binkley N, Clarke BL, Harris ST, Hurley DL, Kleerekoper M, Lewiecki EM, Miller PD, Narula HS, Pessah-Pollack R, Tangpricha V, Wimalawansa SJ, Watts NB
• Relationship Between Gastrointestinal Events and Compliance With Osteoporosis Therapy: An Administrative Claims Analysis of the US Managed Care Population.
  Clinical therapeutics 2016 Modi A, Sajjan S, Michael Lewiecki E, Harris ST, Papadopoulos Weaver J
• Understanding and communicating the benefits and risks of denosumab, raloxifene, and teriparatide for the treatment of osteoporosis.
  Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2013 Lewiecki EM, Miller PD, Harris ST, Bauer DC, Davison KS, Dian L, Hanley DA, McClung MR, Yuen CK, Kendler DL
• Hypoparathyroidism.
  The Journal of clinical endocrinology and metabolism 2013 Bollerslev J, Harris ST, Leder BZ
• Medicines and bone loss.
  The Journal of clinical endocrinology and metabolism 2013 Bollerslev J, Harris ST, Leder BZ
• Before the breaking point: reducing the risk of osteoporotic fracture.
  The Journal of the American Osteopathic Association 2013 Forstein DA, Bernardini C, Cole RE, Harris ST, Singer A
• Bone mineral density in patients with alopecia areata treated with long-term intralesional corticosteroids.
  Journal of drugs in dermatology : JDD 2013 Samrao A, Fu JM, Harris ST, Price VH
• Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday.
  The American journal of medicine 2012 McClung M, Harris ST, Miller PD, Bauer DC, Davison KS, Dian L, Hanley DA, Kendler DL, Yuen CK, Lewiecki EM
• Glucocorticoid-induced osteoporosis.
  The Journal of clinical endocrinology and metabolism 2012 Bollerslev J, Harris ST, Leder BZ
• Bisphosphonates for osteoporosis: benefits and risks.
  The Journal of clinical endocrinology and metabolism 2011 Bollerslev J, Harris ST, Leder BZ
• American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis.
  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2010 Watts NB, Bilezikian JP, Camacho PM, Greenspan SL, Harris ST, Hodgson SF, Kleerekoper M, Luckey MM, McClung MR, Pollack RP, Petak SM, AACE Osteoporosis Task Force
• American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis: executive summary of recommendations.
  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2010 Watts NB, Bilezikian JP, Camacho PM, Greenspan SL, Harris ST, Hodgson SF, Kleerekoper M, Luckey MM, McClung MR, Pollack RP, Petak SM
• Assessing fracture risk and effects of osteoporosis drugs: bone mineral density and beyond.
  The American journal of medicine 2009 Davison KS, Kendler DL, Ammann P, Bauer DC, Dempster DW, Dian L, Hanley DA, Harris ST, McClung MR, Olszynski WP, Yuen CK
• Current and emerging therapies for osteoporosis.
  The Journal of family practice 2009 Mitchner NA, Harris ST
• Risk of severe gastrointestinal events in women treated with monthly ibandronate or weekly alendronate and risedronate.
  The Annals of pharmacotherapy 2009 Blumentals WA, Harris ST, Cole RE, Huang L, Silverman SL
• Preventing nonvertebral osteoporotic fractures with extended-interval bisphosphonates: regimen selection and clinical application.
  Medscape journal of medicine 2009 Cole RE, Harris ST
• Risk of fracture in women treated with monthly oral ibandronate or weekly bisphosphonates: the eValuation of IBandronate Efficacy (VIBE) database fracture study.
  Bone 2009 Harris ST, Reginster JY, Harley C, Blumentals WA, Poston SA, Barr CE, Silverman SL
• Ibandronate and the risk of non-vertebral and clinical fractures in women with postmenopausal osteoporosis: results of a meta-analysis of phase III studies.
  Current medical research and opinion 2008 Harris ST, Blumentals WA, Miller PD
• Progression of efficacy with ibandronate: a paradigm for the development of new bisphosphonates.
  Annals of the New York Academy of Sciences 2007 Zaidi M, Epstein S, Harris ST, Kohles JD, Chesnut CH
• Bisphosphonates and osteonecrosis of the jaw.
  Annals of internal medicine 2006 Watts NB, Harris ST, McClung MR, Bilezikian JP, Greenspan SL, Luckey MM
• Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases.
  Mayo Clinic proceedings 2006 Siris ES, Harris ST, Rosen CJ, Barr CE, Arvesen JN, Abbott TA, Silverman S
• Safety and tolerability of oral daily and intermittent ibandronate are not influenced by age.
  The Journal of rheumatology 2005 Ettinger MP, Felsenberg D, Harris ST, Wasnich R, Skag A, Hiltbrunner V, Wilson K, Schimmer RC, Miller PD
• Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study.
  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2005 Siris ES, Harris ST, Eastell R, Zanchetta JR, Goemaere S, Diez-Perez A, Stock JL, Song J, Qu Y, Kulkarni PM, Siddhanti SR, Wong M, Cummings SR, Continuing Outcomes Relevant to Evista (CORE) …
• Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use.
  Endocrine reviews 2005 Hodsman AB, Bauer DC, Dempster DW, Dian L, Hanley DA, Harris ST, Kendler DL, McClung MR, Miller PD, Olszynski WP, Orwoll E, Yuen CK
• Ibandronate produces significant, similar antifracture efficacy in North American and European women: new clinical findings from BONE.
  Current medical research and opinion 2005 Chesnut CH, Ettinger MP, Miller PD, Baylink DJ, Emkey R, Harris ST, Wasnich RD, Watts NB, Schimmer RC, Recker RR
• Classification algorithms for hip fracture prediction based on recursive partitioning methods.
  Medical decision making : an international journal of the Society for Medical Decision Making 2004 Jin H, Lu Y, Harris ST, Black DM, Stone K, Hochberg MC, Genant HK
• Clinical use of teriparatide in the real world: initial insights.
  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2004 Miller PD, Bilezikian JP, Deal C, Harris ST, Ci RP
• Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial.
  The Journal of clinical endocrinology and metabolism 2002 Delmas PD, Ensrud KE, Adachi JD, Harper KD, Sarkar S, Gennari C, Reginster JY, Pols HA, Recker RR, Harris ST, Wu W, Genant HK, Black DM, Eastell R, Mulitple Outcomes of Raloxifene Evaluation …